Yes! and let's not forget that "no new drugs on the market" incurs in a casualty penalty also... Even if a new drug kills or maims 1% of the patients, if it also saves the lives of 10% of them, what should be the decision?
Copyright © 2017, Eklektix, Inc.
Comments and public postings are copyrighted by their creators.
Linux is a registered trademark of Linus Torvalds